Treatment Details – 9.4 months

Survival: 9.4 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: Netherlands
City/State/Province: Rotterdam
Hospital: University Hospital Rotterdam
Journal: Link
Date: 2/2002

Patients: This Phase II trial involved 32 patients with malignant pleural mesothelioma. None of these patients had received prior chemotherapy.

Treatment: The treatment consisted of two chemotherapy drugs, gemcitabine (gemzar) and cisplatin (platinol).

Toxicity: Grade 4 toxicities included nausea and vomiting. Grade 3 toxicities included hematologic, nausea and vomiting, fatigue anorexia, diarrhea, neurotoxicity, cardiovascular.

Results: The median survival from the start of treatment was 9.4 months.

Support: This study was supported in part by Lilly BV. Lilly markets gemzar.

Correspondence: JP van Meerbeeck, MD

Get your free copy of
“Surviving Mesothelioma” Today!